Literature DB >> 26615597

Spectrum of Mutations in 60 Saudi Patients with Mut Methylmalonic Acidemia.

Faiqa Imtiaz1, Bashayer M Al-Mubarak1, Abeer Al-Mostafa1, Mohamed Al-Hamed1, Rabab Allam1, Zuhair Al-Hassnan2, Mohammed Al-Owain2, Hamad Al-Zaidan2, Zuhair Rahbeeni2, Alya Qari2, Eissa Ali Faqeih3, Ali Alasmari3, Fuad Al-Mutairi4, Majid Alfadhel5,5, Wafaa M Eyaid5,5, Mohamed S Rashed6, Moeenaldeen Al-Sayed7.   

Abstract

Defects in the human gene encoding methylmalonyl-CoA mutase enzyme (MCM) give rise to a rare autosomal recessive inherited disorder of propionate metabolism termed mut methylmalonic acidemia (MMA). Patients with mut MMA have been divided into two subgroups: mut0 with complete loss of MCM activity and mut- with residual activity in the presence of adenosylcobalamin (AdoCbl). The disease typically presents in the first weeks or months of life and is clinically characterized by recurrent vomiting, metabolic acidosis, hyperammonemia, lethargy, poor feeding, failure to thrive and neurological deficit. To better elucidate the spectrum of mutations causing mut MMA in Saudi patients, we screened a cohort of 60 Saudi patients affected by either forms of the disease for mutations in the MUT gene. A total of 13 different mutations, including seven previously reported missense changes and six novel mutations, were detected in a homozygous state except for two compound heterozygous cases. The six novel mutations identified herein consist of three nonsense, two missense and one frameshift, distributed throughout the whole protein. This study describes for the first time the clinical and mutational spectrum of mut MMA in Saudi Arabian patients.

Entities:  

Year:  2015        PMID: 26615597      PMCID: PMC5059185          DOI: 10.1007/8904_2014_297

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  33 in total

1.  Oxidative stress parameters in urine from patients with disorders of propionate metabolism: a beneficial effect of L:-carnitine supplementation.

Authors:  Graziela S Ribas; Giovana B Biancini; Caroline Mescka; Carlos Y Wayhs; Angela Sitta; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2011-07-22       Impact factor: 5.046

2.  Mutation and biochemical analysis of 19 probands with mut0 and 13 with mut- methylmalonic aciduria: identification of seven novel mutations.

Authors:  Thomas J Lempp; Terttu Suormala; Renate Siegenthaler; E Regula Baumgartner; Brian Fowler; Beat Steinmann; Matthias R Baumgartner
Journal:  Mol Genet Metab       Date:  2006-11-20       Impact factor: 4.797

3.  Spectrum of mutations in mut methylmalonic acidemia and identification of a common Hispanic mutation and haplotype.

Authors:  Lisa C Worgan; Kirsten Niles; Jamie C Tirone; Adam Hofmann; Andrei Verner; Alya'a Sammak; Terrence Kucic; Pierre Lepage; David S Rosenblatt
Journal:  Hum Mutat       Date:  2006-01       Impact factor: 4.878

4.  Outcome of individuals with low-moderate methylmalonic aciduria detected through a neonatal screening program.

Authors:  L C Sniderman; M Lambert; R Giguère; C Auray-Blais; B Lemieux; R Laframboise; D S Rosenblatt; E P Treacy
Journal:  J Pediatr       Date:  1999-06       Impact factor: 4.406

5.  Genetic characterization of a MUT locus mutation discriminating heterogeneity in mut0 and mut- methylmalonic aciduria by interallelic complementation.

Authors:  M L Raff; A M Crane; R Jansen; F D Ledley; D S Rosenblatt
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

6.  Long-term follow-up of 77 patients with isolated methylmalonic acidaemia.

Authors:  E R Baumgarter; C Viardot
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

7.  Recognition, isolation, and characterization of rat liver D-methylmalonyl coenzyme A hydrolase.

Authors:  R J Kovachy; S D Copley; R H Allen
Journal:  J Biol Chem       Date:  1983-09-25       Impact factor: 5.157

8.  Expression and kinetic characterization of methylmalonyl-CoA mutase from patients with the mut- phenotype: evidence for naturally occurring interallelic complementation.

Authors:  J Janata; N Kogekar; W A Fenton
Journal:  Hum Mol Genet       Date:  1997-09       Impact factor: 6.150

9.  Neurological outcome of methylmalonic acidaemia.

Authors:  P Nicolaides; J Leonard; R Surtees
Journal:  Arch Dis Child       Date:  1998-06       Impact factor: 3.791

10.  Three novel and six common mutations in 11 patients with methylmalonic acidemia.

Authors:  Azusa Kobayashi; Hiroaki Kakinuma; Hiroaki Takahashi
Journal:  Pediatr Int       Date:  2006-02       Impact factor: 1.524

View more
  4 in total

1.  Peripheral venous route for administration of ammonul infusion for treatment of acute hyperammonemia. An experience from a tertiary center in Saudi Arabia.

Authors:  Amal M Alhashem; Rihab M Salih; Aida I Al-Aqeel; Sarar Mohamed
Journal:  Saudi Med J       Date:  2020-01       Impact factor: 1.484

2.  IDENTIFICATION OF A NOVEL MUTATION IN THE MMAA GENE IN A CHINESE BOY WITH ISOLATED METHYLMALONIC ACIDEMIA.

Authors:  D Tang; G Chen; S Liu
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Apr-Jun       Impact factor: 0.877

3.  Incidence of maple syrup urine disease, propionic acidemia, and methylmalonic aciduria from newborn screening data.

Authors:  Kimberly A Chapman; Gwendolyn Gramer; Sarah Viall; Marshall L Summar
Journal:  Mol Genet Metab Rep       Date:  2018-04-05

4.  Methylmalonic Acidemia with Novel MUT Gene Mutations.

Authors:  Inusha Panigrahi; Savita Bhunwal; Harish Varma; Simranjeet Singh
Journal:  Case Rep Genet       Date:  2017-10-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.